DiscoverNEJM This Week
NEJM This Week
Claim Ownership

NEJM This Week

Author: NEJM Group

Subscribed: 16,160Played: 222,137
Share

Description

Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.
47 Episodes
Reverse
This week, we look at new trials on glucocorticoids for pneumonia in Africa, shunting for normal-pressure hydrocephalus, and pegcetacoplan for two rare kidney diseases. We review updated vaccine evidence for Covid-19, RSV, and influenza, and present a case of respiratory decline and muscle weakness. Perspectives explore health care incentives, U.S. global health strategy, and bringing AI-enabled care to rural America. Supplement to the New England Journal of Medicine, Vol. 393, No. 22.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
loading
Comments (2)

ali_mostafa_zadeh

is there any transcript for this podcast?

Sep 26th
Reply

Iman

That's excellent, I hope to continue!

Jul 16th
Reply